Enovix Q3 net loss $82M; shifts focus to Gen2 Autoline, guides lower 2023 output

Enovix Corp

2022-Q3 EPS reported -$0.55 revenue$5,109,000

GAAP net loss $82.0M ($0.53 EPS) includes $50.2M warrant fair-value loss; non-GAAP loss $23.2M ($0.15 EPS).
Revenue $8K; FY 2022 revenue guidance $6-8M; cash use guidance lowered to $130-150M.
Scaling back Gen1 throughput in Fab-1; targeting Gen2 Autoline with 9M+ cells/year at full ramp.
Signed non-binding MOU with Strategic Account for wearable/mobile/computing; MOU with IPG Photonics for laser tech.
Revenue funnel $1.4B; design wins grew to 9; end-Q3 cash $349.0M.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Enovix Corp reported financial results for the third fiscal quarter ended October 2, 2022.

Period: the third fiscal quarter ended October 2, 2022
Result: reported results

Exact text from the filing

On November 1, 2022, Enovix Corporation released its financial results for the third fiscal quarter ended October 2, 2022, by posting its Third Quarter 2022 Update, a letter to its shareholders, on its website.

View on SEC.gov

3 earnings releases filed in the last 30 days. Browse all earnings releases →

Enovix Corp filing history →

Source: SEC EDGAR

accession 0001828318-22-000059

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.